OBJECTIVES: We undertook this study to determine if treatment candidacy and outcomes were similar between elderly and non-elderly patients. METHODS: This was a prospective cohort study that screened 4,025 patients with chronic hepatitis C for HCV antiviral treatment at 24 Veterans Affairs Medical Centers throughout the country. We used multivariable logistic regression to determine whether there was an independent association between being elderly (age > 60 vs. <or= 60) and (1) being considered a treatment candidate by clinician, and (2) achieving sustained virologic response if treated. RESULTS: 364 of the 4,025 patients (9%) were over the age of 60. Only 25% of patients over the age of 60 were considered to be treatment candidates by the evaluating clinician, and only 10% were started on treatment. After adjustment for potential confounders, older age remained associated with a lower likelihood of being considered a treatment candidate (adjusted OR = 0.43; 95% CI: 0.30-0.61). Although based on a small sample of elderly treated patients (n = 35), being elderly did not appear to be associated with a lower likelihood of achieving SVR (adjusted OR = 1.54; 95% CI: 0.46-5.15). CONCLUSION: Among veterans over the age of 60 with chronic hepatitis C who are referred for treatment, relatively few are considered treatment candidates and an even smaller number are ultimately treated. After adjusting for co-morbidities, age remains a strong predictor of not being a treatment candidate. In contrast, older age does not seem to adversely affect treatment outcomes and side effects.
OBJECTIVES: We undertook this study to determine if treatment candidacy and outcomes were similar between elderly and non-elderly patients. METHODS: This was a prospective cohort study that screened 4,025 patients with chronic hepatitis C for HCV antiviral treatment at 24 Veterans Affairs Medical Centers throughout the country. We used multivariable logistic regression to determine whether there was an independent association between being elderly (age > 60 vs. <or= 60) and (1) being considered a treatment candidate by clinician, and (2) achieving sustained virologic response if treated. RESULTS: 364 of the 4,025 patients (9%) were over the age of 60. Only 25% of patients over the age of 60 were considered to be treatment candidates by the evaluating clinician, and only 10% were started on treatment. After adjustment for potential confounders, older age remained associated with a lower likelihood of being considered a treatment candidate (adjusted OR = 0.43; 95% CI: 0.30-0.61). Although based on a small sample of elderly treated patients (n = 35), being elderly did not appear to be associated with a lower likelihood of achieving SVR (adjusted OR = 1.54; 95% CI: 0.46-5.15). CONCLUSION: Among veterans over the age of 60 with chronic hepatitis C who are referred for treatment, relatively few are considered treatment candidates and an even smaller number are ultimately treated. After adjusting for co-morbidities, age remains a strong predictor of not being a treatment candidate. In contrast, older age does not seem to adversely affect treatment outcomes and side effects.
Authors: Edmund J Bini; Norbert Bräu; Sue Currie; Hui Shen; Bhupinderjit S Anand; Ke-Qin Hu; Lennox Jeffers; Samuel B Ho; David Johnson; Warren N Schmidt; Paul King; Ramsey Cheung; Timothy R Morgan; Joseph Awad; Marcos Pedrosa; Kyong-Mi Chang; Ayse Aytaman; Franz Simon; Curt Hagedorn; Richard Moseley; Jawad Ahmad; Charles Mendenhall; Bradford Waters; Doris Strader; Anna W Sasaki; Stephen Rossi; Teresa L Wright Journal: Am J Gastroenterol Date: 2005-08 Impact factor: 10.864
Authors: N Horiike; T Masumoto; K Nakanishi; K Michitaka; K Kurose; I Ohkura; M Onji Journal: J Gastroenterol Hepatol Date: 1995 May-Jun Impact factor: 4.029
Authors: Claudia Roeder; Sabine Jordan; Julian Schulze Zur Wiesch; Heike Pfeiffer-Vornkahl; Dietrich Hueppe; Stefan Mauss; Elmar Zehnter; Sabine Stoll; Ulrich Alshuth; Ansgar W Lohse; Stefan Lueth Journal: World J Gastroenterol Date: 2014-08-21 Impact factor: 5.742
Authors: Myrna L Cozen; James C Ryan; Hui Shen; Ramsey Cheung; David E Kaplan; Christine Pocha; Norbert Brau; Ayse Aytaman; Warren N Schmidt; Marcos Pedrosa; Bhupinderjit S Anand; Kyong-Mi Chang; Timothy Morgan; Alexander Monto Journal: Dig Dis Sci Date: 2016-04-08 Impact factor: 3.199
Authors: Umberto Vespasiani-Gentilucci; Giovanni Galati; Paolo Gallo; Antonio De Vincentis; Elisabetta Riva; Antonio Picardi Journal: World J Gastroenterol Date: 2015-06-28 Impact factor: 5.742
Authors: Claus Niederau; Dietrich Hüppe; Elmar Zehnter; Bernd Möller; Renate Heyne; Stefan Christensen; Rainer Pfaff; Arno Theilmeier; Ulrich Alshuth; Stefan Mauss Journal: World J Gastroenterol Date: 2012-03-28 Impact factor: 5.742